Brandon May

Brandon May is a freelance medical writer and owner of May Medical Communications, LLC. He holds a BS in Nutrition and Dietetics from the University of Houston. Throughout his career, he has written over 700 medical news articles across several different therapeutic areas. In addition to covering the medical news, Brandon also creates content for continuing medical education providers, hospitals, and pharmaceutical and medical device companies across the globe.

All articles by Brandon May

Pulmonary Hypertension

Idiopathic Pulmonary Arterial Hypertension and Risk for Cardiac Events

Brandon May

March 1, 2018

Peak circulatory power offers greater value than peak oxygen uptake and ventilation in predicting cardiac events in patients with idiopathic PAH.

Pulmonary Hypertension

Hypoxemia in Idiopathic Pulmonary Arterial Hypertension Linked to Increased Mortality

Brandon May

March 1, 2018

Hypoxemia in individuals with idiopathic PAH is associated with increased mortality risk.

Practice Management

Physician-Hospital Consolidation May Increase With 340B Drug Pricing Program Participation

Brandon May

February 9, 2018

Physician-hospital consolidation may increase with 340B drug pricing program participation.

Pulmonary Hypertension

Performing Two 6MWTs in Pulmonary Hypertension Minimizes “Learning Effect”

Brandon May

February 8, 2018

Patients with suspected PH should undergo two 6MWTs to improve the accuracy of exercise capacity measurements.

Pulmonary Medicine

International Liaison Committee on Resuscitation: Updated Treatment Consensus for CPR

Brandon May

January 12, 2018

The International Liaison Committee on Resuscitation has provided treatment updates on various aspects of CPR.

Pulmonary Hypertension

REVEAL Risk Score for Long-Term Outcomes in PAH

Brandon May

January 4, 2018

The REVEAL risk score gives significant predictive value for long-term survival and changes in mortality risk in patients with PAH.

Medicine and law, gavel, prescription, stethoscope

Practice Management

Researchers Publishing “Unfavorable” Results May Face Legal Action From Pharmaceutical Companies

Brandon May

January 3, 2018

Researchers continue to be the targets of legal action from pharmaceutical, medical device, and nutraceutical companies when their studies frame products in an unfavorable light.